Aurinia Pharmaceuticals Inc (AUPH) Event Aug. 04, 2022, 00:00 UTC (28% Negative) Aurinia Pharmaceuticals Inc. (AUPH) Reports 33% Loss Increase for 2022-06-30 Full text
Register to leave comments News bot Oct. 29, 2025, 10:48 a.m. 🏢 Aurinia Pharmaceuticals Inc (AUPH) - Form 10-Q Quarterly Report Quarterly financial filing submitted to the SEC 📋 Filing Information 📄 Form Type: 10-Q 📅 Filing Date: 2022-08-04 📊 Period of Report: 2022-06-30 ⏰ Accepted: N/A 📊 Key Financial Metrics (Period-over-Period Comparison) Metric Current Period Previous Period Change ($) Change (%) Trend Net Income/Loss $-97.39M $-73.14M $-24.24M -33.15% 📈 Total Assets $543.37M $482.15M $61.22M +12.70% 📈 Total Liabilities $64.28M $58.38M $5.90M +10.10% 📉 Stockholders' Equity $332.26M $-672.54M $1.00B +149.40% 📈 Operating Income/Loss $-97.68M $-73.87M $-23.81M -32.23% 📈 R&D Expense $4.00M $19.92M $-15.92M -79.92% 📈 Earningspersharebasic $-0.76 $-0.52 $-0.24 -46.15% 📉 Earningspersharediluted $-0.76 $-0.52 $-0.24 -46.15% 📉 Costofrevenue $356.00K $1.85M $-1.50M -80.81% 📉 📈 Financial Trend Analysis 🔻 Reported net loss for the period • 🏦 Strengthened balance sheet with assets growing faster than liabilities 📎 View Full 10-Q Filing on SEC.gov Access the complete official filing document
🏢 Aurinia Pharmaceuticals Inc (AUPH) - Form 10-Q Quarterly Report
📋 Filing Information
Key Financial Metrics (Period-over-Period Comparison)
Financial Trend Analysis
🔻 Reported net loss for the period • 🏦 Strengthened balance sheet with assets growing faster than liabilities
📎 View Full 10-Q Filing on SEC.gov
Access the complete official filing document